Emulate Secures $28,000,000 Series B Financing

  • Feed Type
  • Date
    3/28/2016
  • Company Name
    Emulate
  • Mailing Address
    27 Drydock Avenue 5th Floor Cambridge, MA 02210 USA
  • Company Description
    Emulate launches to commercialize automated human Organs-on-Chips platform to accelerate drug development, detect toxicities and advance personalized medicine.
  • Website
    http://www.emulatebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $28,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B funding will position Emulate to accelerate its R&D effort, expedite the launch of its products and expand strategic relationships with industry and academic partners in order to evolve the company towards profitability.
  • M&A Terms
  • Venture Investor
    NanoDimension
  • Venture Investor
    Cedars-Sinai Medical Center
  • Venture Investor
    OS Fund
  • Venture Investor
    Atel Ventures
  • Venture Investor
    Investor

Trending on Xconomy